$DCTH
Delcath Systems Inc

2019 Q2 Form 10-Q Financial Statement

#000156459019030871 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $410.0K $858.0K
YoY Change -52.21% 46.92%
Cost Of Revenue $172.0K $220.0K
YoY Change -21.82% 57.14%
Gross Profit $240.0K $638.0K
YoY Change -62.38% 42.09%
Gross Profit Margin 58.54% 74.36%
Selling, General & Admin $2.653M $2.640M
YoY Change 0.49% 4.35%
% of Gross Profit 1105.42% 413.79%
Research & Development $1.714M $4.089M
YoY Change -58.08% 62.39%
% of Gross Profit 714.17% 640.91%
Depreciation & Amortization $100.0K $100.0K
YoY Change 0.0% 0.0%
% of Gross Profit 41.67% 15.67%
Operating Expenses $4.367M $6.730M
YoY Change -35.11% 33.27%
Operating Profit -$4.127M -$6.092M
YoY Change -32.26% 32.41%
Interest Expense -$1.837M -$560.0K
YoY Change 228.04% -91.94%
% of Operating Profit
Other Income/Expense, Net $1.000K -$5.000K
YoY Change -120.0%
Pretax Income -$5.960M -$6.660M
YoY Change -10.51% 243.3%
Income Tax
% Of Pretax Income
Net Earnings -$5.959M -$6.658M
YoY Change -10.5% 242.67%
Net Earnings / Revenue -1453.41% -775.99%
Basic Earnings Per Share -$58.50 -$7.26
Diluted Earnings Per Share -$58.50 -$7.26
COMMON SHARES
Basic Shares Outstanding 101.9K 916.7K
Diluted Shares Outstanding 101.9K 916.7K

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $350.0K $1.280M
YoY Change -72.66% -29.67%
Cash & Equivalents $352.0K $2.345M
Short-Term Investments
Other Short-Term Assets $1.720M $1.410M
YoY Change 21.99% -90.02%
Inventory $687.0K $1.250M
Prepaid Expenses
Receivables $180.0K $400.0K
Other Receivables $0.00 $30.00K
Total Short-Term Assets $2.945M $4.370M
YoY Change -32.61% -74.84%
LONG-TERM ASSETS
Property, Plant & Equipment $805.0K $1.099M
YoY Change -26.75% -10.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.691M $1.103M
YoY Change 143.97% -10.33%
TOTAL ASSETS
Total Short-Term Assets $2.945M $4.370M
Total Long-Term Assets $2.691M $1.103M
Total Assets $5.636M $5.473M
YoY Change 2.98% -70.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.71M $5.607M
YoY Change 91.06% 466.36%
Accrued Expenses $9.119M $5.220M
YoY Change 74.69% 134.08%
Deferred Revenue
YoY Change
Short-Term Debt $9.840M $0.00
YoY Change
Long-Term Debt Due $520.0K $390.0K
YoY Change 33.33% -96.9%
Total Short-Term Liabilities $31.25M $18.10M
YoY Change 72.66% 5.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $30.00K
YoY Change -100.0%
Other Long-Term Liabilities $122.0K $439.0K
YoY Change -72.21% -17.17%
Total Long-Term Liabilities $122.0K $439.0K
YoY Change -72.21% -17.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.25M $18.10M
Total Long-Term Liabilities $122.0K $439.0K
Total Liabilities $35.37M $18.56M
YoY Change 90.51% 4.64%
SHAREHOLDERS EQUITY
Retained Earnings -$357.9M -$324.3M
YoY Change 10.36%
Common Stock $183.0K $9.000K
YoY Change 1933.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K
YoY Change
Treasury Stock Shares $1.00
Shareholders Equity -$29.73M -$13.09M
YoY Change
Total Liabilities & Shareholders Equity $5.636M $5.473M
YoY Change 2.98% -70.58%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$5.959M -$6.658M
YoY Change -10.5% 242.67%
Depreciation, Depletion And Amortization $100.0K $100.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$3.190M -$2.840M
YoY Change 12.32% -34.26%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K
YoY Change -100.0% -86.36%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$30.00K
YoY Change -100.0% -86.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.320M 2.400M
YoY Change 38.33% -2100.0%
NET CHANGE
Cash From Operating Activities -3.190M -2.840M
Cash From Investing Activities 0.000 -30.00K
Cash From Financing Activities 3.320M 2.400M
Net Change In Cash 130.0K -470.0K
YoY Change -127.66% -89.91%
FREE CASH FLOW
Cash From Operating Activities -$3.190M -$2.840M
Capital Expenditures $0.00 -$30.00K
Free Cash Flow -$3.190M -$2.810M
YoY Change 13.52% -31.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-16133
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
061245881
dei Entity Address Address Line1
EntityAddressAddressLine1
1633 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22C
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
489-2100
dei Entity Shell Company
EntityShellCompany
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18277807
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Trading Symbol
TradingSymbol
DCTH
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
352000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2516000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1062000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1062000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
180000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
585000
CY2019Q2 us-gaap Inventory Net
InventoryNet
687000
CY2018Q4 us-gaap Inventory Net
InventoryNet
858000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
664000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
898000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
2945000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
5919000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
805000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
925000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1886000
CY2019Q2 us-gaap Assets
Assets
5636000
CY2018Q4 us-gaap Assets
Assets
6844000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10713000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7715000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9119000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7964000
CY2019Q2 us-gaap Notes Payable Current
NotesPayableCurrent
9838000
CY2019Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
523000
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2038000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1050000
CY2019Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9000
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
33000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31252000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17750000
CY2019Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3143000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3405000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
848000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
122000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
628000
CY2019Q2 us-gaap Liabilities
Liabilities
35365000
CY2018Q4 us-gaap Liabilities
Liabilities
21783000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
183000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
103000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
328018000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
328962000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357907000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-344054000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
50000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-29729000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-14939000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5636000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6844000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
101
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
101
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18277807
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10299954
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18277807
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10299954
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
172000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
220000
us-gaap Cost Of Revenue
CostOfRevenue
268000
CY2019Q2 us-gaap Gross Profit
GrossProfit
240000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2653000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1714000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4089000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4367000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
6730000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17209000
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000
CY2018Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2826000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2826000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1837000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-5959000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6658000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23000
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-78000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5982000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6694000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13927000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
449000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71303364
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
916706
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72069390
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
788512
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71303364
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
916706
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72069390
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
799430
CY2018Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:500
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.002
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
54000
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-1160000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7894000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-23778000
CY2019Q2 dcth Stock Issued During Period Value Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodValueExchangeOfWarrantsForCommonStock
14000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-80000
CY2018Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
14000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4251000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18306000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
7185000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-34000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-6205000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
-47000
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-95000
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-41000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-44000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13090000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
129000
dcth Stock Option Compensation Income Expense
StockOptionCompensationIncomeExpense
-40000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
4000
dcth Restricted Stock Compensation Income Expense
RestrictedStockCompensationIncomeExpense
-81000
us-gaap Depreciation
Depreciation
122000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
552000
dcth Amortization Of Right Of Use Assets
AmortizationOfRightOfUseAssets
0
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
0
dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
us-gaap Paid In Kind Interest
PaidInKindInterest
329000
us-gaap Paid In Kind Interest
PaidInKindInterest
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3444000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-318000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-404000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
163000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-143000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-43000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3827000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3985000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-240000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-504000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
44000
dcth Principal Payments On Leases
PrincipalPaymentsOnLeases
540000
dcth Principal Payments On Leases
PrincipalPaymentsOnLeases
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5962000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9277000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3719000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
dcth Proceeds From Sale Of Common Stock And Warrants
ProceedsFromSaleOfCommonStockAndWarrants
0
dcth Proceeds From Sale Of Common Stock And Warrants
ProceedsFromSaleOfCommonStockAndWarrants
4210000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2172000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3869000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6382000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-69000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-45000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2979000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5324000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2164000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1414000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2345000
dcth Non Cash Activities Fair Value Of Warrants Issued
NonCashActivitiesFairValueOfWarrantsIssued
0
dcth Non Cash Activities Fair Value Of Warrants Issued
NonCashActivitiesFairValueOfWarrantsIssued
23532000
CY2019Q2 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
1012000
CY2018Q4 dcth Letters Of Credit Restricted Cash
LettersOfCreditRestrictedCash
1012000
CY2019Q2 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2018Q4 dcth Security For Credit Cards Restricted Cash
SecurityForCreditCardsRestrictedCash
50000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
307000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
358000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
380000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
500000
CY2019Q2 us-gaap Prepaid Insurance
PrepaidInsurance
175000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
140000
CY2019Q2 dcth Sublease Income Current
SubleaseIncomeCurrent
127000
CY2019Q2 dcth Financing Costs Current
FinancingCostsCurrent
80000
CY2019Q2 us-gaap Security Deposit
SecurityDeposit
50000
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
51000
CY2019Q2 dcth Income Tax And Value Added Tax Receivable Current
IncomeTaxAndValueAddedTaxReceivableCurrent
31000
CY2018Q4 dcth Income Tax And Value Added Tax Receivable Current
IncomeTaxAndValueAddedTaxReceivableCurrent
579000
CY2019Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
201000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
128000
CY2019Q2 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2018Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5232000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5232000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4427000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4307000
CY2019Q2 us-gaap Depreciation
Depreciation
100000
CY2018Q2 us-gaap Depreciation
Depreciation
100000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3469000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1785000
CY2019Q2 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
4289000
CY2018Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
4530000
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
731000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
402000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
630000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1247000
CY2019Q2 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2018Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
us-gaap Operating Lease Cost
OperatingLeaseCost
587000
dcth Financing Lease Cost
FinancingLeaseCost
19000
us-gaap Sublease Income
SubleaseIncome
308000
us-gaap Lease Cost
LeaseCost
298000
us-gaap Operating Lease Payments
OperatingLeasePayments
628000
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
308000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
24000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
874000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
579000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1149000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
314000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2042000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
144000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1898000
CY2019Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10500000
CY2019Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
200000
CY2019Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
10300000
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2500000
CY2018Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1250000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
83333
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1166667
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
399998
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.28
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.28
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.28
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.28
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P7M6D
CY2019Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
75000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
133000
CY2018Q2 dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
-140000
dcth Share Based Compensation Income Expense
ShareBasedCompensationIncomeExpense
-121000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
65685269
dcth Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
7898853
dcth Stock Issued During Period Shares Exchange Of Warrants For Common Stock
StockIssuedDuringPeriodSharesExchangeOfWarrantsForCommonStock
64000
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
57722416
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.22
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.23
CY2018Q4 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.22
dcth Class Of Warrant Or Right Weighted Average Exercise Price Exercises In Period
ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
0.01
CY2019Q2 dcth Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.23
CY2018 dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y9M
dcth Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P5Y2M26D
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
33000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
17000
dcth Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Reclassified From Liability To Equity
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisReclassifiedFromLiabilityToEquity
7000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9000
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-619000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13853000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-92000
dcth Number Of Shares Pre Funded Penny Warrants Outstanding
NumberOfSharesPreFundedPennyWarrantsOutstanding
53400000
CY2019Q2 dcth Weighted Average Number Of Shares Issued
WeightedAverageNumberOfSharesIssued
17910886000
dcth Weighted Average Number Of Shares Issued
WeightedAverageNumberOfSharesIssued
18676912000
CY2019Q2 dcth Weighted Average Number Of Shares Pre Funded Warrants
WeightedAverageNumberOfSharesPreFundedWarrants
53392478000
dcth Weighted Average Number Of Shares Pre Funded Warrants
WeightedAverageNumberOfSharesPreFundedWarrants
53392478000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71303364000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72069390000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5830302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3232551
CY2018Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
2100000
CY2019Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2000000
CY2019Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08

Files In Submission

Name View Source Status
0001564590-19-030871-index-headers.html Edgar Link pending
0001564590-19-030871-index.html Edgar Link pending
0001564590-19-030871.txt Edgar Link pending
0001564590-19-030871-xbrl.zip Edgar Link pending
dcth-10q_20190630.htm Edgar Link pending
dcth-20190630.xml Edgar Link completed
dcth-20190630.xsd Edgar Link pending
dcth-20190630_cal.xml Edgar Link unprocessable
dcth-20190630_def.xml Edgar Link unprocessable
dcth-20190630_lab.xml Edgar Link unprocessable
dcth-20190630_pre.xml Edgar Link unprocessable
dcth-ex311_7.htm Edgar Link pending
dcth-ex312_9.htm Edgar Link pending
dcth-ex321_8.htm Edgar Link pending
dcth-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending